Human nutrition and genetic variation

Food and Nutrition Bulletin

Volumn 28, Issue 1 SUPPL. 1, 2007, Pages

  Stover, Patrick J ^a  

^a Division of Nutritional Sciences ^*  (United States)

Author keywords

Genome; Nutrients; Nutrition; Polymorphism; Requirements; Variation

Indexed keywords

GENETIC VARIATION; NUTRIENT; NUTRITION; POLYMORPHISM;

EID: 34047182610     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265070281s109     Document Type: Article

References (137)

1. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677→T polymorphism affect cancer risk: Intake recommendations. J Nutr 2003;133(11 suppl 1):3748S-53S.
2. Bailey LB, Gregory JF 3rd. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919-22.
3. Tishkoff SA, Williams SM. Genetic analysis of African populations: Human evolution and complex disease. Nat Rev Genet 2002;3:611-21.
4. McCarthy JJ, Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 2000;18:505-8.
5. Weinshilboum R. Inheritance and drug response. N Engl J Med 2003;348:529-37.
6. Clark AG, Glanowski S, Nielsen R, Thomas PD, Kejariwal A, Todd MA, Tanenbaum DM, Civello D, Lu F, Murphy B, Ferriera S, Wang G, Zheng X, White TJ, Sninsky JJ, Adams MD, Cargill M. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science 2003;302:1960-3.
7. Vijg J, Suh Y. Genetics of longevity and aging. Annu Rev Med 2005;56:193-212.
8. Kornman KS, Martha PM, Duff GW. Genetic variations and inflammation: A practical nutrigenomics opportunity. Nutrition 2004;20-44-9.
9. Schneeman BO, Mendelson R. Dietary guidelines: Past experience and new approaches. J Am Diet Assoc 2002;102:1498-500.
10. Schneeman BO. Evolution of dietary guidelines. J Am Diet Assoc 2003;103(12 suppl 2):S5-9.
11. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002;30:233-7.
12. Tishkoff SA, Verrelli BC. Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet 2003;4:293-340.
13. Guttmacher AE, Collins FS. Genomic medicine - A primer. N Engl J Med 2002;347:1512-20.
14. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51.
15. Tishkoff SA, Kidd KK. Implications of biogeography of human populations for 'race' and medicine. Nat Genet 2004;36(11 suppl):S21-7.
16. Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans. Genetics 2000;156:297-304.
17. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 2003;4:587-97.
18. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
19. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med 2005;56: 303-20.
20. Van Blerkom LM. Role of viruses in human evolution. Am J Phys Anthropol 2003;suppl 37:14-46.
21. Brookfield JF. Mobile DNAs: The poacher turned game-keeper. Curr Biol 2003;13:R846-7.
22. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002;3:370-9.
23. Bamshad M, Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet 2003;4:99-111.
24. Waterland RA, Jirtle RL. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
25. Friso S, Choi SW. Gene-nutrient interactions and DNA methylation. J Nutr 2002;132(8 suppl):2382S-7S.
26. Friso S, Choi SW, Dolnikowski GG, Selhub J. A method to assess genomic DNA methylation using high-performance liquid chromatography/ electrospray ionization mass spectrometry. Anal Chem 2002;74:4526-31.
27. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr 1999;69:179-97.
28. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-5.
29. Fenech M. Micronutrients and genomic stability: A new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol 2002;40:1113-7.
30. Fenech M. Genome health nutrigenomics: Nutrition and the science of optimal genome maintenance. Asia Pac J Clin Nutr 2004;13(suppl):S15.
31. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002;7:1128-37.
32. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 2001;480-481:51-4.
33. Mishra HN, Das C. A review on biological control and metabolism of aflatoxin. Crit Rev Food Sci Nutr 2003; 43:245-64.
34. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001;475:7-20.
35. Goswami T, Rolfs A, Hediger MA. Iron transport: Emerging roles in health and disease. Biochem Cell Biol 2002;80:679-89.
36. Hediger MA, Rolfs A, Goswami T. Iron transport and hemochromatosis. J Investig Med 2002;50:239S-46S.
37. Wolfe KH, Li WH. Molecular evolution meets the genomics revolution. Nat Genet 2003;33 suppl:255-65.
38. Cooper DN, Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 1989;83:181-8.
39. Kimura M. Evolutionary rate at the molecular level. Nature 1968;217:624-6.
40. King JL, Jukes TH. Non-Darwinian evolution. Science 1969;164:788-98.
41. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 2002;12:1805-14.
42. Akey JM, Eberle MA, Rieder MJ, Carlson CS, Shriver MD, Nickerson DA, Kruglyak L. Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol 2004;2:e286.
43. Wooding S. Natural selection: Sign, sign, everywhere a sign. Curr Biol 2004;14:R700-1.
44. Collins FS. What we do and don't know about 'race,' 'ethnicity', genetics and health at the dawn of the genome era. Nat Genet 2004;36(11 suppl):S13-5.
45. Chakravarti A. To a future of genetic medicine. Nature 2001;409:822-3.
46. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
47. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001;69:124-37.
48. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: Common disease-common variant...or not? Hum Mol Genet 2002;11:2417-23.
49. Jorde LB, Watkins WS, Bamshad MJ. Population genomics: A bridge from evolutionary history to genetic medicine. Hum Mol Genet 2001;10:2199-207.
50. Jorde LB, Watkins WS, Bamshad MJ, Dixon ME, Ricker CE, Seielstad MT, Batzer MA. The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet 2000;66:979-88.
51. Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat Genet 2004;36(11 suppl):S28-33.
52. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, Rhodes M, Reich DE, Hirschhorn JN. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 2004; 74:1111-20.
53. Poulter M, Hollox E, Harvey CB, Mulcare C, Peuhkuri K, Kajander K, Sarner M, Korpela R, Swallow DM. The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet 2003;67(pt 4):298-311.
54. Wooding S. PopHist: Inferring population history from the spectrum of allele frequencies. Bioinformatics 2003;19:539-40.
55. Toomajian C, Ajioka RS, Jorde LB, Kushner JP, Kreitman M. A method for detecting recent selection in the human genome from allele age estimates. Genetics 2003;165:287-97.
56. Toomajian C, Kreitman M. Sequence variation and haplotype structure at the human HFE locus. Genetics 2002;161:1609-23.
57. Beutler E. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am J Clin Nutr 2004;80: 799-800.
58. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 1986;6:502-10.
59. Osier MV, Pakstis AJ, Soodyall H, Comas D, Goldman D, Odunsi A, Okonofua F, Parnas J, Schulz LO, Bertranpetit J, Bonne-Tamir B, Lu RB, Kidd JR, Kidd KK. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet 2002;71:84-99.
60. Loew M, Boeing H, Sturmer T, Brenner H. Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gamma-glutamyltransferase. Alcohol 2003;29:131-5.
61. Oota H, Pakstis AJ, Bonne-Tamir B, Goldman D, Grigorenko E, Kajuna SL, Karoma NJ, Kungulilo S, Lu RB, Odunsi K, Okonofua F, Zhukova OV, Kidd JR, Kidd KK. The evolution and population genetics of the ALDH2 locus: Random genetic drift, selection, and low levels of recombination. Ann Hum Genet 2004;68(pt 2): 93-109.
62. Neel JV. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962;14:353-62.
63. Diamond J. The double puzzle of diabetes. Nature 2003;423:599-602.
64. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002;19:1991-2004.
65. Verrelli BC, McDonald JH, Argyropoulos G, Destro-Bisol G, Froment A, Drousiotou A, Lefranc G, Helal AN, Loiselet J, Tishkoff SA. Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet 2002;71:1112-28.
66. Watkins WS, Rogers AR, Ostler CT, Wooding S, Bamshad MJ, Brassington AM, Carroll ML, Nguyen SV, Walker JA, Prasad BY, Reddy PG, Das PK, Batzer MA, Jorde LB. Genetic variation among world populations: Inferences from 100 Alu insertion polymorphisms. Genome Res 2003;13:1607-18.
67. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG. Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science 2001;293:455-62.
68. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106: R69-73.
69. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-97.
70. Wray GA, Hahn MW, Abouheif E, Balhoff JP, Pizer M, Rockman MV, Romano LA. The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol 2003;20:1377-419.
71. Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet 1999;23:397-404.
72. Wooding S, Kim UK, Bamshad MJ, Larsen J, Jorde LB, Drayna D. Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 2004;74:637-46.
73. Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002;75:616-58.
74. Young VR. 2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President's Lecture: Human nutrient requirements: The challenge of the post-genome era. J Nutr 2002;132:621-9.
75. Siegal ML, Bergman A. Waddington's canalization revisited: Developmental stability and evolution. Proc Natl Acad Sci USA 2002;99:10528-32.
76. Greenspan RJ. The flexible genome. Nat Rev Genet 2001;2:383-7.
77. Stover PJ. Nutritional genomics. Physiol Genomics 2004;16:161-5.
78. 12 in health and disease. Nutr Rev 2004;62(6 pt 2):S3-12; discussion S13.
79. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, Swanson DA. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/ formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 2002;71:1207-15.
80. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098-102.
81. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999;6:359-65.
82. Esposito G, Vitagliano L, Santamaria R, Viola A, Zagari A, Salvatore F. Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett 2002;531:152-6.
83. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000;67:881-900.
84. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet 2004;5:71-118.
85. Ordovas JM. The quest for cardiovascular health in the genomic era: Nutrigenetics and plasma lipoproteins. Proc Nutr Soc 2004;63:145-52.
86. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982;38:447-53.
87. Edwards RG. Recent scientific and medical advances in assisted human conception. Int J Dev Biol 1997;41: 255-62.
88. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil Steril 2000;74: 1196-9.
89. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000;95:519-24.
90. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998;128:1336-41.
91. Shelnutt KP, Kauwell GP, Gregory JF 3rd, Maneval DR, Quinlivan EP, Theriaque DW, Henderson GN, Bailey LB. Methylenetetrahydrofolate reductase 677→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 2004;15:554-60.
92. Hunt JR, Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 2004;80:924-31.
93. Swanson CA. Iron intake and regulation: Implications for iron deficiency and iron overload. Alcohol 2003;30:99-102.
94. Moirand R, Guyader D, Mendler MH, Jouanolle AM, Le Gall JY, David V, Brissot P, Deugnier Y. HFE based re-evaluation of heterozygous hemochromatosis. Am J Med Genet 2002;111:356-61.
95. Baier LJ, Hanson RL. Genetic studies of the etiology of type 2 diabetes in Pima Indians: Hunting for pieces to a complicated puzzle. Diabetes 2004;53:1181-6.
96. Tseung CW, McMahon LG, Vazquez J, Pohl J, Gregory JF 3rd. Partial amino acid sequence and mRNA analysis of cytosolic pyridoxine-beta-D-glucoside hydrolase from porcine intestinal mucosa: Proposed derivation from the lactase-phlorizin hydrolase gene. Biochem J 2004; 380(pt 1):211-8.
97. Mackey AD, McMahon RJ, Townsend JH, Gregory JF 3rd. Uptake, hydrolysis, and metabolism of pyridoxine-5′-beta-D-glucoside in Caco-2 cells. J Nutr 2004;134:842-6.
98. Seifried HE, Anderson DE, Sorkin BC, Costello RB. Free radicals: The pros and cons of antioxidants. Executive summary report. J Nutr 2004;134:3143S-63S.
99. Zeisel SH. Antioxidants suppress apoptosis. J Nutr 2004;134:3179S-80S.
100. Csete M, Doyle J. Bow ties, metabolism and disease. Trends Biotechnol 2004;22:446-50.
101. Pennisi E. Evolution of developmental diversity. Evodevo devotees eye ocular origins and more. Science 2002;296:1010-1.
102. Pasqualetti M, Neun R, Davenne M, Rijli FM. Retinoic acid rescues inner ear defects in Hoxal deficient mice. Nat Genet 2001;29:34-9.
103. Finnell RH, Spiegelstein O, Wlodarczyk B, Triplett A, Pogribny IP, Melnyk S, James JS. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr 2002;132(8 suppl):2457S-61S.
104. Seckl JR, Meaney MJ. Glucocorticoid programming. Ann NY Acad Sci 2004;1032:63-84.
105. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142:1371-6.
106. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 2005;85:571-633.
107. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004;151(suppl 3):U49-62.
108. White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135-56.
109. Bertram C, Trowern AR, Copin N, Jackson AA, Whorwood CB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: Potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 2001;142:2841-53.
110. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol 2005;288:R34-8.
111. Gatford KL, Wintour EM, De Blasio MJ, Owens JA, Dodic M. Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin Sci (Lond) 2000;98:553-60.
112. Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:9151-4.
113. Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos S, Proietto J. Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 1993;7:1456-62.
114. Asipu A, Hayward BE, O'Reilly J, Bonthron DT. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 2003;52:2426-32.
115. Cox TM. The genetic consequences of our sweet tooth. Nat Rev Genet 2002;3:481-7.
116. Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: Tubuloglomerular feedback and renal injury in African Americans. Kidney Int 2004;65:361-8.
117. Messier W, Stewart CB. Episodic adaptive evolution of primate lysozymes. Nature 1997;385:151-4.
118. Zhang J, Zhang YP, Rosenberg HF. Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nat Genet 2002;30:411-5.
119. Wu W, Goodman M, Lomax MI, Grossman LI. Molecular evolution of cytochrome C oxidase subunit IV: Evidence for positive selection in simian primates. J Mol Evol 1997;44:477-91.
120. Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB. DNA sequence variation in a 3.7-kb noncoding sequence 5′ of the CYP1A2 gene: Implications for human population history and natural selection. Am J Hum Genet 2002;71:528-42.
121. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
122. Tsai MY, Yang F, Bignell M, Aras O, Hanson NQ. Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5′-phosphate concentration. Mol Genet Metab 1999;67:352-6.
123. Afman LA, Trijbels FJ, Blom HJ. The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J Nutr 2003;133:75-7.
124. Devlin AM, Ling EH, Peerson JM, Fernando S, Clarke R, Smith AD, Halsted CH. Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 2000;9:2837-44.
125. Uitterlinden AG, Fang Y, Bergink AP, van Meurs JB, van Leeuwen HP, Pols HA. The role of vitamin D receptor gene polymorphisms in bone biology. Mol Cell Endocrinol 2002;197:15-21.
126. Griffiths W, Cox T. Haemochromatosis: Novel gene discovery and the molecular pathophysiology of iron metabolism. Hum Mol Genet 2000;9:2377-82.
127. Zhao R, Russell RG, Wang Y, Liu L, Gao F, Kneitz B, Edelmann W, Goldman ID. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 2001; 276:10224-8.
128. Geller DS. A genetic predisposition to hypertension? Hypertension 2004;44:27-8.
129. Jeck N, Waldegger S, Lampert A, Boehmer C, Waldegger P, Lang PA, Wissinger B, Friedrich B, Risler T, Moehle R, Lang UE, Zill P, Bondy B, Schaeffeler E, Asante-Poku S, Seyberth H, Schwab M, Lang F. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 2004;43:1175-81.
130. Bentzen J, Jorgensen T, Fenger M. The effect of six polymorphisms in the apolipoprotein B gene on parameters of lipid metabolism in a Danish population. Clin Genet 2002;61:126-34.
131. Hubacek JA, Pistulkova H, Skodova Z, Berg K, Poledne R. Association between apolipoprotein B promotor haplotypes and cholesterol status. Ann Clin Biochem 2001;38(pt 4):399-400.
132. Brown S. Ordovas JM, Campos H. Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins. Atherosclerosis 2003;170:307-13.
133. Hein DW. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002;506-507:65-77.
134. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29-42.
135. Ferre N, Camps J, Fernandez-Ballart J, Arija V, Murphy MM, Ceruelo S, Biarnes E, Vilella E, Tous M, Joven J. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 2003;49:1491-7.
136. Chistyakov DA, Savost'anov KV, Zotova EV, Nosikov VV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet 2001;2:4.
137. Van Landeghem GF, Tabatabaie P, Kucinskas V, Saha N, Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered 1999;49:190-3.